Maju Mathews Selected Research

asenapine

1/2018	Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
1/2017	Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study.
1/2017	Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
1/2017	Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder.
1/2016	Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
12/2015	Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
6/2015	Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maju Mathews Research Topics

Disease

28	Schizophrenia (Dementia Praecox) 01/2021 - 02/2005
13	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2004
5	Anxiety Disorders (Anxiety Disorder) 01/2017 - 06/2015
4	Psychomotor Agitation (Akathisia) 01/2019 - 06/2015
4	Weight Gain 01/2017 - 06/2015
4	Nausea 12/2016 - 11/2014
4	Diarrhea 12/2016 - 11/2014
3	Treatment-Resistant Depressive Disorder 01/2022 - 01/2020
3	Neuroleptic Malignant Syndrome 03/2019 - 01/2006
3	Sleepiness 01/2018 - 06/2015
3	Mania (Manias) 01/2018 - 01/2016
3	Dizziness (Lightheadedness) 01/2017 - 06/2015
3	Fatigue 12/2016 - 01/2014
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2016 - 01/2007
3	Psychotic Disorders (Schizoaffective Disorder) 07/2009 - 01/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2017 - 06/2015
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2017 - 03/2015
2	Vomiting 06/2015 - 03/2015
1	Dyskinesias (Dyskinesia) 01/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Tremor (Tremors) 01/2019
1	Pain (Aches) 10/2018
1	Injection Site Reaction 10/2018
1	Hypesthesia (Numbness) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Dysgeusia (Parageusia) 01/2017
1	Ejaculatory Dysfunction 12/2016
1	Erectile Dysfunction 12/2016
1	Hyperprolactinemia 07/2009
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2009
1	Prolactinoma (Prolactinomas) 07/2009
1	Opioid-Related Disorders (Opiate Addiction) 03/2007
1	Sialorrhea 01/2007
1	Autistic Disorder (Autism) 03/2006
1	Thrombocytopenia (Thrombopenia) 01/2006
1	Mental Disorders (Mental Disorder) 11/2005
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2005
1	Movement Disorders (Movement Disorder) 03/2005

Drug/Important Bio-Agent (IBA)

25	Paliperidone Palmitate FDA Link 01/2021 - 10/2016
13	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 03/2005
11	Vilazodone HydrochlorideIBA 01/2017 - 01/2014
7	asenapine FDA Link 01/2018 - 06/2015
4	EsketamineIBA 01/2022 - 01/2020
4	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2018 - 02/2005
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2016 - 03/2015
3	Antidepressive Agents (Antidepressants)IBA 01/2022 - 01/2021
3	Nasal SpraysIBA 01/2022 - 01/2021
3	Aripiprazole (Abilify)FDA Link 01/2018 - 03/2007
3	5-HT1A Serotonin ReceptorIBA 12/2016 - 06/2015
2	Olanzapine (Zyprexa)FDA Link 01/2017 - 01/2017
1	BenzodiazepinesIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	LithiumIBA 01/2017
1	Citalopram FDA LinkGeneric 07/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	Serotonin (5 Hydroxytryptamine)IBA 11/2014
1	Haloperidol (Haldol)FDA LinkGeneric 07/2009
1	ProlactinIBA 07/2009
1	Dopamine Agonists (Dopamine Agonist)IBA 07/2009
1	Buprenorphine (Subutex)FDA LinkGeneric 03/2007
1	Acetylcarnitine (Alcar)IBA 01/2007
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2007
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2006
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2006
1	Sertraline (Zoloft)FDA LinkGeneric 01/2004

Therapy/Procedure

16	Injections 01/2021 - 10/2016
2	Therapeutics 01/2020 - 01/2017
2	Secondary Prevention 01/2020 - 01/2019
1	Transcranial Magnetic Stimulation 11/2005